Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.4926
-0.0323 (-6.16%)
Jan 16, 2026, 4:00 PM EST
Aspira Women's Health Market Cap
Aspira Women's Health has a market cap or net worth of $21.42 million as of January 20, 2026. Its market cap has increased by 82.26% in one year.
Market Cap
21.42M
Enterprise Value
20.19M
Revenue
9.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.49
Market Cap Chart
Since September 29, 2000, Aspira Women's Health's market cap has decreased from 229.08M to 21.42M, a decrease of -90.65%. That is a compound annual growth rate of -8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 21.42M | -20.30% |
| Dec 31, 2025 | 26.87M | 128.70% |
| Dec 31, 2024 | 11.75M | -72.14% |
| Dec 29, 2023 | 42.17M | 1.77% |
| Dec 30, 2022 | 41.44M | -79.12% |
| Dec 31, 2021 | 198.46M | -71.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |